Veterinary Vaccines Market 2023: R&D Consistency Drives Sector GrowthPosted by Ganesh Shinde on February 24th, 2023 In the next decade, the veterinary vaccine market is expected to increase from US$ 11.3 Billion to US$ 20.82 Billion. This is predicted to drive the market share of veterinary vaccines by 6.2% between 2023 and 2033. Through the control and prevention of serious epidemic diseases, veterinary vaccines are often crucial to animal health protection. The veterinary vaccines market is forecast to grow throughout the forecast years primarily due to the high adoption of pets worldwide. Furthermore, there is a persistent economic slowdown, rising storage costs, and an increase in vegetarianism that limit the market's growth. With lower costs, more investments in animal health, and skilled professionals, it could enjoy lucrative growth. Veterinary vaccines are becoming increasingly popular due to their ability to protect both animal health and public health. This is because they mimic naturally acquired immunity. Veterinary vaccine sales are particularly high in developed nations due to increased pet ownership. Animals benefit greatly from these vaccines as they prolong their lifespan and keep them healthy. Key Takeaways from Market Study
Competitive Landscape: Several prominent companies dominate this market, including Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health, Merck & Co., Inc., Bayer AG, Virbac Group, Ceva Santé Animale, Phibro Animal Health Corporation, and others. Read More@ https://www.futuremarketinsights.com/reports/veterinary-vaccines-market Veterinary Vaccines Market Segmentation by Category By Product:
By Disease:
By Distribution Channel:
By Species:
Like it? Share it!More by this author |